Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2015 16:05 ET | Source: Novavax, Inc.

Novavax Announces Management Promotion

GAITHERSBURG, Md., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Jill Hoyt has been named Vice President, Human Resources & Administration. Ms. Hoyt joined...
January 07, 2015 10:08 ET | Source: Novavax, Inc.

Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 26, 2014 08:30 ET | Source: Novavax, Inc.

Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 20, 2014 08:30 ET | Source: Novavax, Inc.

U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization

GAITHERSBURG, Md., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 17, 2014 16:05 ET | Source: Novavax, Inc.

Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP

GAITHERSBURG, Md., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 13, 2014 09:23 ET | Source: Novavax, Inc.

Novavax to Present at the Jefferies Global Healthcare Conference

GAITHERSBURG, Md., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 10, 2014 08:30 ET | Source: Novavax, Inc.

Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects

GAITHERSBURG, Md., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 06, 2014 17:19 ET | Source: Novavax, Inc.

Novavax and Collaborators Make Multiple Presentations at the 9th International Respiratory Syncytial Virus Symposium in South Africa, November 9-13, 2014

GAITHERSBURG, Md., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
November 05, 2014 16:13 ET | Source: Novavax, Inc.

Novavax Reports Third Quarter 2014 Financial Results

GAITHERSBURG, Md., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...
October 30, 2014 08:30 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014

GAITHERSBURG, Md., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant...